VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
163 hedge funds and large institutions have $1.08B invested in Verve Therapeutics in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+6
Holders Change %
+3.82%
% of All Funds
2.36%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
27
Increased
74
Reduced
40
Closed
20
Calls
$1.81M
Puts
$2.91M
Net Calls
-$1.1M
Net Calls Change
-$670K
Top Buyers
| 1 |
1
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$60.8M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$67.7M |
| 3 |
3
BlackRock
New York
|
$71.4M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$84.1M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$15.6M |
Top Sellers
| 1 |
AIM
1
ARK Investment Management
St. Petersburg,
Florida
|
$80.2M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$19.8M |
| 3 |
3
Federated Hermes
Pittsburgh,
Pennsylvania
|
$47.2M |
| 4 |
4
Jane Street
New York
|
$360K |
| 5 |
5
Squarepoint
New York
|
$1.11M |
